David S. Goldfarb, MD, FACP, FASN, FNKF
Nephrology Division, New York University Langone Medical Center, New York, NY, USA
David S. Goldfarb is a Professor of Medicine and Physiology at NYU School of Medicine, Clinical Chief of Nephrology at NYU, Chief of Nephrology at the NY VAMC and co-director of the Kidney Stone Prevention Program at NYU Langone Medical Center. He graduated from Yale College and Yale School of Medicine a long time ago. He completed his residency training in internal medicine and his nephrology training at NYU/New York VA. Dr. Goldfarb is the former President of the New York Society of Nephrology and of the ROCK Society. He serves as the principal investigator of the cystinuria component of the NIH-sponsored Rare Kidney Stone Consortium, and as a member of the board of directors of the International Cystinuria Foundation. He received the “Stone Crusher of the Year” award in 2014 from the Oxalosis and Hyperoxaluria Foundation and the “Nephrologist of the Year” award in 2016 from the American Kidney Fund. He has had three calcium oxalate stones.